Biotech
Major bio firm Alteogen seeks KOSPI listing
Ti AI ṣe iroyin Àwòrán tí AI ṣe
Alteogen, the top market cap company on South Korea's secondary KOSDAQ market, has decided to move to the main KOSPI bourse to secure stable funding and enhance its corporate value. Shareholders approved the proposal on Monday, with the firm aiming for a listing next year.
Biotech company Guard Therapeutics has received conditional approval from Nasdaq Stockholm for continued listing of its shares on Nasdaq First North.
Ti AI ṣe iroyin
Researchers have demonstrated that quantum computers can enhance generative Artificial Intelligence models for drug discovery. The work focused on generating new peptides and was completed as a side project using leftover resources.
Brain implant developer Paradromics has secured approval from the US Food and Drug Administration to conduct an early-stage human trial for its device. The Austin-based startup aims to test the high-bandwidth implant to restore speech in individuals with extremely limited movement. The company announced the milestone on Thursday.
Ti AI ṣe iroyin
An experimental gene-editing therapy from Crispr Therapeutics has successfully reduced high cholesterol levels in a small group of patients. This development marks a step toward broader applications of Crispr technology in treating heart disease.
A new treatment tested in brain organoids with glioblastoma outperformed chemotherapy and dramatically reduced tumors in mice. Human trials are upcoming. The approach also explores stem cell stimulation and aging cell rejuvenation for broader immunotherapy applications.
Ti AI ṣe iroyin
Summit's new drug for lung cancer demonstrated promising results in recent assessments. This development is part of ongoing biotech advancements in oncology. It was reported alongside other health innovations.
Three patients receive cancer-detecting brain implants
May 04, 2026 21:50Nuvation Bio holds Q1 2026 earnings call
April 24, 2026 17:54Isomorphic Labs’ AI-designed drugs advance to human trials
April 06, 2026 23:47Chinese regulator discourages red-chip structures in sensitive industries
March 17, 2026 16:03US reshoring casts shadow over China’s contract drug makers, analyst says
November 07, 2025 13:42U.S. startups secure $2 billion in top funding rounds this week
November 04, 2025 16:52Researchers develop light-based cancer treatment sparing healthy cells
October 27, 2025 03:28Beyond Meat investor eyes ETHZilla after stock rally
September 15, 2025 00:14Stem Cell EVs Aid Tissue Repair
September 15, 2025 00:14Vaccine Therapy Progress for Brain Tumors